December 25, 2019
ASKA Pharmaceutical filed a new drug application in Japan for its investigational oral uterine fibroid treatment ulipristal, also known as CDB-2914, on December 24, the company said. An oral progesterone receptor modulator, ulipristal was licensed from French partner Laboratoire HRA...read more